Literature DB >> 12946471

Fusion of contrast-enhanced breast MR and mammographic imaging data.

Christian P Behrenbruch1, Kostas Marias, Paul A Armitage, Margaret Yam, Niall Moore, Ruth E English, Jane Clarke, Michael Brady.   

Abstract

Increasing use is being made of Gd-DTPA contrast-enhanced magnetic resonance imaging for breast cancer assessment since it provides 3D functional information via pharmacokinetic interaction between contrast agent and tumour vascularity, and because it is applicable to women of all ages as well as patients with post-operative scarring. Contrast-enhanced MRI (CE-MRI) is complementary to conventional X-ray mammography, since it is a relatively low-resolution functional counterpart of a comparatively high-resolution 2D structural representation. However, despite the additional information provided by MRI, mammography is still an extremely important diagnostic imaging modality, particularly for several common conditions such as ductal carcinoma in situ (DCIS) where it has been shown that there is a strong correlation between microcalcification clusters and malignancy. Pathological indicators such as calcifications and fine spiculations are not visible in CE-MRI and therefore there is clinical and diagnostic value in fusing the high-resolution structural information available from mammography with the functional data acquired from MRI imaging. This paper presents a novel data fusion technique whereby medial-lateral oblique (MLO) and cranial-caudal (CC) mammograms (2D data) are registered to 3D contrast-enhanced MRI volumes. We utilise a combination of pharmacokinetic modelling, projection geometry, wavelet-based landmark detection and thin-plate spline non-rigid 'warping' to transform the coordinates of regions of interest (ROIs) from the 2D mammograms to the spatial reference frame of the contrast-enhanced MRI volume. Of key importance is the use of a flexible wavelet-based feature extraction technique that enables feature correspondences to be robustly determined between the very different image characteristics of X-ray mammography and MRI. An evaluation of the fusion framework is demonstrated with a series of clinical cases and a total of 14 patient examples.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12946471     DOI: 10.1016/s1361-8415(03)00015-x

Source DB:  PubMed          Journal:  Med Image Anal        ISSN: 1361-8415            Impact factor:   8.545


  7 in total

1.  Hybrid PET-optical imaging using targeted probes.

Authors:  Matthias Nahrendorf; Edmund Keliher; Brett Marinelli; Peter Waterman; Paolo Fumene Feruglio; Lioubov Fexon; Misha Pivovarov; Filip K Swirski; Mikael J Pittet; Claudio Vinegoni; Ralph Weissleder
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

2.  Combined PET/CT colonography: is this the way forward?

Authors:  A G Schreyer; R Kikinis
Journal:  Gut       Date:  2006-01       Impact factor: 23.059

3.  Simulation of mammographic breast compression in 3D MR images using ICP-based B-spline deformation for multimodality breast cancer diagnosis.

Authors:  Julia Krüger; Jan Ehrhardt; Arpad Bischof; Heinz Handels
Journal:  Int J Comput Assist Radiol Surg       Date:  2014-01-16       Impact factor: 2.924

4.  2D/3D image fusion of X-ray mammograms with breast MRI: visualizing dynamic contrast enhancement in mammograms.

Authors:  Torsten Hopp; Pascal Baltzer; Matthias Dietzel; Werner A Kaiser; Nicole V Ruiter
Journal:  Int J Comput Assist Radiol Surg       Date:  2011-06-05       Impact factor: 2.924

5.  Semiautomated multimodal breast image registration.

Authors:  Charlotte Curtis; Richard Frayne; Elise Fear
Journal:  Int J Biomed Imaging       Date:  2012-02-01

6.  Using x-ray mammograms to assist in microwave breast image interpretation.

Authors:  Charlotte Curtis; Richard Frayne; Elise Fear
Journal:  Int J Biomed Imaging       Date:  2012-03-22

7.  Integration of vibro-acoustography imaging modality with the traditional mammography.

Authors:  H Gholam Hosseini; A Alizad; M Fatemi
Journal:  Int J Biomed Imaging       Date:  2007
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.